Micrornas: Key Players in Virus-Associated Hepatocellular Carcinoma Publisher Pubmed



Sadri Nahand J¹ ; Bokharaeisalim F¹ ; Salmaninejad A^{2, 3} ; Nesaei A⁴ ; Mohajeri F⁵ ; Moshtzan A⁵ ; Tabibzadeh A¹ ; Karimzadeh M¹ ; Moghoofei M⁶ ; Marjani A¹ ; Yaghoubi S⁵ ; Keyvani H¹ Show Affiliations
Source: Journal of Cellular Physiology Published:2019

Abstract

Hepatocellular carcinoma (HCC) is known as one of the major health problems worldwide. Pathological analysis indicated that a variety of risk factors including genetical (i.e., alteration of tumor suppressors and oncogenes) and environmental factors (i.e., viruses) are involved in beginning and development of HCC. The understanding of these risk factors could guide scientists and clinicians to design effective therapeutic options in HCC treatment. Various viruses such as hepatitis B virus (HBV) and hepatitis C virus (HCV) via targeting several cellular and molecular pathways involved in HCC pathogenesis. Among various cellular and molecular targets, microRNAs (miRNAs) have appeared as key players in HCC progression. miRNAs are short noncoding RNAs which could play important roles as oncogenes or tumor suppressors in several malignancies such as HCC. Deregulation of many miRNAs (i.e., miR-222, miR-25, miR-92a, miR-1, let-7f, and miR-21) could be associated with different stages of HCC. Besides miRNAs, exosomes are other particles which are involved in HCC pathogenesis via targeting different cargos, such as DNAs, RNAs, miRNAs, and proteins. In this review, we summarize the current knowledge of the role of miRNAs and exosomes as important players in HCC pathogenesis. Moreover, we highlighted HCV- and HBV-related miRNAs which led to HCC progression. © 2018 Wiley Periodicals, Inc.